SOURCE-LINKED STUDY SUMMARY
Selective androgen receptor modulator, YK11, regulates myogenic differentiation of C2C12 myoblasts by follistatin expression.
Abstract summarizedQuality not appraised
- What was studied
- The study examined how YK-11 affects muscle-cell development and follistatin, a protein involved in muscle biology.
- Who / model studied
- C2C12 muscle precursor cells were studied.
- Studied dose & schedule
- Dose and schedule were not reported in the source used for this summary.
- What the study found
- YK-11 increased follistatin and muscle-development markers. Blocking follistatin reversed the effect on cell development.
- Limitations & context
- These are cell findings; this experiment does not establish muscle growth or safety in people.
Read summary source ↗ · Prepared 9/15/2026 · AI-assisted, source-based summary
Review record & corrections
Summary prepared: . Source scope: abstract. This is an AI-assisted source summary, not an independent clinician sign-off.
No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.
Inspect the source · Correction policyResearch findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.
Original publication ↗ · DOI: 10.1248/bpb.b13-00231